News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–23
Matches
23
Sources here
8
Companies here
1
Search results Stored financial headlines

Active search

23 matching headlines

Ticker or company: MRKRMain company stories
Clear
Latest

TradingView Earnings

Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Marker Therapeutics Inc is projected to report a loss of 22 cents per share. This information comes from an earnings preview. The full article content requires unlimited access to TradingView.

Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Marker Therapeutics Inc (MRKR) has an earnings forecast score of 8.00, ranking 171st in the Biotechnology & Medical Research industry. Analysts have set an average price target of $9.00 for MRKR, with expectations for its next quarter's revenue at $682.00K and EPS at -$0.22. …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Institutional Confidence

Marker Therapeutics Inc (MRKR) has an institutional shareholding score of 3.00, placing it 191st out of 384 in the Biotechnology & Medical Research industry. Institutional shareholding proportion increased by 17.09% quarter-over-quarter to 26.04%. James Simons is identified as the largest institutional shareholder, albeit with …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Marker Therapeutics Inc (MRKR), highlighting its current risk score and beta value. It details the company's performance metrics, including volatility, maximum drawdown, and daily returns over various periods. The assessment also includes liquidity measures like turnover rate …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MRKR|Marker Therapeutics Inc|Price:1.110|

This article provides a comprehensive stock analysis of Marker Therapeutics Inc (MRKR) by TradingKey, highlighting the company's strong fundamentals and significant growth potential despite a weak recent stock market performance. It notes a "Buy" consensus from multiple analysts with a higher price target, but …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MRKR|Marker Therapeutics Inc|Price:1.120|Chg%:-0.060

This article provides a detailed financial overview of Marker Therapeutics Inc. (MRKR), including its real-time stock quotes, market cap, and a comprehensive breakdown of its income statement, balance sheet, and cash flow statement. It highlights the latest earnings report, key financial indicators like EPS, …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Marker Therapeutics Inc (MRKR), highlighting its current valuation score and P/E ratio. The company's valuation score is 6.03, ranking it low in the Biotechnology & Medical Research industry. The P/E ratio is -2.18, significantly below its recent …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Marker Therapeutics Inc (MRKR) from FY2012Q1 through FY2026Q1, covering operating, investing, and financing activities. It presents financial figures alongside year-over-year percentage changes, offering insight into the company's financial performance. The document also …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings

The article details the shareholder structure of Marker Therapeutics Inc (MRKR), identifying its major shareholders and institutional holdings. Key shareholders include New Enterprise Associates (NEA), John Robert Wilson, Blue Owl Capital Holdings LP, and Vanguard Capital Management, LLC. The report also provides a breakdown …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Marker Therapeutics Inc (MRKR), highlighting that the company has not yet disclosed relevant data regarding its business segments or regional revenue and profit contribution. It notes the stock's current performance, market capitalization, and P/E TTM. The lack …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Marker Therapeutics Inc (MRKR), highlighting its robust financial status and high operating efficiency. The company's financial score is 7.92, ranking 71st in the Biotechnology & Medical Research industry, with recent quarterly revenue increasing by 115.32% year-over-year and …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Marker Therapeutics Inc (MRKR), detailing its current price momentum, support and resistance levels, and indicator readings. The stock is currently trading between a resistance of 1.56 and a support of 1.05. The analysis includes various technical indicators …

MRKR main company
Sharemaestro market context Price below Trend Line 52 weeks -11.6% MRKR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context